Literature DB >> 7389255

Prazosin kinetics in essential hypertension.

N P Chau, B L Flouvat, E Le Roux, M E Safar.   

Abstract

Prazosin kinetics were studied in 8 hypertensive patients (4 male and 4 female) with normal renal function. Intravenous data showed a 3-phase distribution. As a result, a linear 3-compartment model with elimination from the central compartment was proposed to describe the drug kinetics. Prazosin disappeared from plasma with a terminal half-life t1/2 of about 3 hr and had a central distribution volume of about 0.18 1/kg. Only a negligible fraction of the dose was found unchanged in urine. The oral data showed that, of the 2-mg dose, about 1 mg was effectively absorbed. This fraction was almost entirely absorbed in 2 hr. Absorption kinetics were apparently linear with a t1/2 of about 30 min.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389255     DOI: 10.1038/clpt.1980.123

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

Review 1.  Effects of cardiovascular disease on pharmacokinetics.

Authors:  V Rodighiero
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

Review 2.  Clinical pharmacokinetics of prazosin--1985.

Authors:  J Vincent; P A Meredith; J L Reid; H L Elliott; P C Rubin
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.